Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
blueprint medicines
boston blog main
boston top stories
3
×
eli lilly
3
×
life sciences
national blog main
san francisco blog main
avapritinib
boston
cancer
cancer drugs
clinical trials
europe blog main
fda
genentech
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
san francisco top stories
selpercatinib
thyroid cancer
black diamond therapeutics
bladder cancer
capmatinib
cstone pharmaceuticals
deals
deciphera pharmaceuticals
endometral cancer
europe top stories
european medicines agency
european society for medical oncology
fisogatinib
flatiron health
gastrointestinal stromal tumors
glioblastoma
hepatocellular carcinoma
indiana blog main
What
cancer
3
×
drug
3
×
medicines
approval
blueprint
fda
ret
address
approves
biotech
black
candidate
carries
certain
clinic
companies
currently
designed
diamond
eluded
genetic
hopes
ipo
latest
lead
leading
lines
marketing
molecular
muscle
nears
new
pact
pass
phase
ready
regulatory
research
review
roche
Language
unset
Current search:
drug
×
" boston top stories "
×
cancer
×
" eli lilly "
×
@xconomy.com
4 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic